Vis enkel innførsel

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID‑19 (Bari‑SolidAct): a randomised, double‑blind, placebo‑controlled phase 3 trial

dc.contributor.authorTrøseid, Marius
dc.contributor.authorArribas, José R.
dc.contributor.authorAssoumou, Lambert
dc.contributor.authorHolten, Aleksander Rygh
dc.contributor.authorPoissy, Julien
dc.contributor.authorTerzic, Vida
dc.contributor.authorMazzaferri, Fulvia
dc.contributor.authorBaño, Jesús Rodríguez
dc.contributor.authorEustace, Joe
dc.contributor.authorHites, Maya
dc.contributor.authorJoannidis, Michael
dc.contributor.authorPaiva, José-Artur
dc.contributor.authorReuter, Jean
dc.contributor.authorPüntmann, Isabel
dc.contributor.authorPatrick-Brown, Thale Dawn
dc.contributor.authorWesterheim, Elin
dc.contributor.authorNezvalova-Henriksen, Katerina
dc.contributor.authorBeniguel, Lydie
dc.contributor.authorDahl, Tuva Børresdatter
dc.contributor.authorBouscambert, Maude
dc.contributor.authorHalanova, Monika
dc.contributor.authorPéterfi, Zoltán
dc.contributor.authorTsiodras, Sotirios
dc.contributor.authorRezek, Michael
dc.contributor.authorBriel, Matthias
dc.contributor.authorÜnal, Serhat
dc.contributor.authorSchlegel, Martin
dc.contributor.authorAder, Florence
dc.contributor.authorLacombe, Karine
dc.contributor.authorAmdal, Cecilie Delphin
dc.contributor.authorRodrigues, Serge
dc.contributor.authorTonby, Kristian
dc.contributor.authorGaudet, Alexandre
dc.contributor.authorHeggelund, Lars
dc.contributor.authorMootien, Joy
dc.contributor.authorJohannessen, Asgeir
dc.contributor.authorMøller, Jannicke Horjen
dc.contributor.authorPollan, Beatriz Diaz
dc.contributor.authorTveita, Anders Aune
dc.contributor.authorKildal, Anders Benjamin
dc.contributor.authorRichard, Jean-Christophe
dc.contributor.authorDalgard, Olav
dc.contributor.authorSimensen, Victoria Charlotte
dc.contributor.authorBaldé, Aliou
dc.contributor.authorde Gastines, Lucie
dc.contributor.authordel Álamo, Marta
dc.contributor.authorAydin, Burç
dc.contributor.authorLund-Johansen, Fridtjof
dc.contributor.authorTrabaud, Mary-Anne
dc.contributor.authorDiallo, Alpha
dc.contributor.authorHalvorsen, Bente
dc.contributor.authorRøttingen, John-Arne
dc.contributor.authorTacconelli, Evelina
dc.contributor.authorYazdanpanah, Yazdan
dc.contributor.authorOlsen, Inge Christoffer
dc.contributor.authorCostagliola, Dominique
dc.contributor.authorStudy Group, EU-SolidAct
dc.date.accessioned2023-05-03T10:14:10Z
dc.date.available2023-05-03T10:14:10Z
dc.date.created2023-01-10T16:38:24Z
dc.date.issued2023
dc.identifier.citationCritical Care. 2023, 27 (9), .
dc.identifier.issn1364-8535
dc.identifier.urihttps://hdl.handle.net/11250/3065952
dc.language.isoeng
dc.titleEfficacy and safety of baricitinib in hospitalized adults with severe or critical COVID‑19 (Bari‑SolidAct): a randomised, double‑blind, placebo‑controlled phase 3 trial
dc.title.alternativeEfficacy and safety of baricitinib in hospitalized adults with severe or critical COVID‑19 (Bari‑SolidAct): a randomised, double‑blind, placebo‑controlled phase 3 trial
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber15
dc.source.volume27
dc.source.journalCritical Care
dc.source.issue9
dc.identifier.doi10.1186/s13054-022-04205-8
dc.identifier.cristin2104449
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail
Filnavn:
BariSolidActCritCare.pdf
Størrelse:
1.287Mb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel